期刊文献+

O157:H7大肠杆菌外膜蛋白对小鼠免疫保护作用的实验研究 被引量:9

The study for the immuno-protection of E.coli O157:H7 outer membrane protein
原文传递
导出
摘要 目的 研究经不同免疫途径 ,O1 5 7:H7大肠杆菌外膜蛋白 (OMP)对小鼠接受致死剂量该菌攻击后的免疫保护作用。方法 用外膜蛋白分别通过鼻腔、口腔和皮下途径对雌性BALB/c小鼠免疫 3次 ,采用ELISA测定血、阴道冲洗液和粪便内抗体水平 ;用Western 印迹方法分析诱导小鼠产生抗外膜蛋白特异性抗体的抗原 ;用致死剂量O1 5 7:H7大肠杆菌活菌经口腔攻毒 ,观察记录动物的发病与死亡情况 ;观察受染动物器官病理变化。结果 ELISA结果表明 ,经鼻腔与口腔免疫 ,能有效诱导抗外膜蛋白IgA和IgG免疫应答 ,鼻腔免疫更为有效。经皮下免疫仅能诱导血中产生高水平的特异性IgG抗体。攻毒后 ,鼻腔和口腔免疫组小鼠存活率明显高于对照组 (86 7%比 4 0 % ,P <0 0 1和 73 3%比 4 0 % ,P <0 0 5 ) ,鼻腔免疫组更高 (86 7%比 73 3% ,P <0 0 5 )。而皮下免疫组存活率甚至低于对照组 (1 3 3%比 4 0 % ,P <0 0 5 )。结论 O1 5 7:H7大肠杆菌外膜蛋白对实验小鼠的该菌株致死剂量攻击有较强的保护作用。鼻腔免疫途径为O1 5 Objective To evaluate the protective efficacy against a lethal dose of E coli O157:H7 after intranasal, oral and subcutaneous immunization with the outer membrane protein(OMP) extracted from the whole cell of E coli O157:H7 Methods Female BALB/C mice were immunized three times(on days 0,7 and 14) with OMP and CT or Complete Frund adjuvant On the 21st day after the last immunization, serum, fecal extracts and vaginal washes were collected for the detection of antigen specific antibody responses by ELISA before the oral challenge with E coli O157: H7 933 And the antigens that induced the specific antibody responses were analysed by Western blotting Then, the mice were orally challenged with 0 3 ml 4 25×10 10 /ml live E coli O157: H7, and the mortality was recorded On the 7th day after the challenge, the mice were sacrificed and the heart, liver, lung, kidney, small intestine and colon were collected Then the histology lesions were observed by light microscopy Results In ELISA, both intranasal and oral immunization, with CT as a mucosal adjuvant, induced strong anti OMP IgA responses in serum, fecal extract and vaginal washes, and anti OMP IgG responses in serum However, the intranasal immunization was much more effective to induce specific IgA and IgG responses than the oral immunization In contrast to mucosal immunization, subcutaneous immunization only induced high levels of specific IgG antibodies in serum, and did not effectively promote IgA immune response The results of the protective efficacy after challenge showed that both intranasal and oral immunizations with OMP provided significant protection (86 7% to 40%, P <0 01 and 73 3% to 40%, P <0 05)against a lethal dose of E coli O157:H7 challenge, and intranasal immunization possessed a better protective ability (86 7% to 73 3%, P <0 05) In contrast, the mice immunized subcutaneously were not protected They were died more early after oral challenge Furthermore, the histopathological features of the kidney, colon and other organs also appeared to be well correlated with immunization route In comparison with the mice immunized subcutaneously and those in control group, the severity of the histopathological lesions in the tissues of the mice immunized intranasally was minimal Conclusion These results suggested that the intranasal immunization should be the best choice of vaccine development against E coli O157:H7
出处 《中华医学杂志》 CAS CSCD 北大核心 2004年第1期58-62,共5页 National Medical Journal of China
关键词 大肠杆菌O157:H7 细菌外膜蛋白质 免疫保护 特异性抗体 动物模型 Escherichia coli O157 Immunity,mucosal Bacterial outer membrane proteins IgA
  • 相关文献

参考文献11

  • 1Konadu E, Donohue-Rolfe A, Calderwood SB, et al. Syntheses and immunologic properties of Escherichia coli O157 O-specific polysaccharide and Shiga toxin 1 B subunit conjugates in mice. Infect Immun, 1999, 67:6191-6193.
  • 2Dean-Nystrom EA, Gansheroff LJ, Mills M, et al. Vaccination of pregnant dams with intimin(O157) protects suckling piglets from Escherichia coli O157:H7 infection. Infect Immun, 2002, 70:2414-2418.
  • 3Gansheroff LJ, Wachtel MR, O'Brien AD. Decreased adherence of Enterohemorrhagic Escherichia coli to Hep-2 cells in the presence of antibodies that recognize the C-terminal region of Intimin. Infect Immun, 1999, 67: 6409-6417.
  • 4Sherman PM, Soni R. Adherence of Vero cytotoxin-producing Escherichia coli of serotype O157:H7 to human epithelial cells in tissue culture: role of outer membranes as bacterial adhesins. J Med Microbiol, 1988, 26:11-17.
  • 5Achtman M, Mercer A, Kusecek B, et al. Six Widespread Bacterial Clones Among Escherichia coli K1 Isolates. Infect Immun, 1983, 39:315-335.
  • 6Pascale JM, Shaw MM, Durant PJ, et al. Intranasal immunization confers protection against murine Pneumocysis carinii lung infection. Infect Immun, 1999, 67:805-809.
  • 7Rudin A, Johansson EL, Bergquist C, et al. Differential kinetics and distribution of antibodies in serum and nasal and vaginal secretions after nasal and oral vaccination of human. Infect Immun, 1998, 66:3390-3396.
  • 8Conlan JW, Cox AD, KuoLee R, et al. Parenteral immunization with a glycoconjugate vaccine containing the O157 antigen of Escherichia coli O157:H7 elicits a systemic humoral immune response in mice, but fails to prevent colonization by the pathogen. Can J
  • 9Michetti P, Mahan MJ, Slauch JM, et al. Monoclonal secretory immunoglobulin A protects mice against oral challenge with the invasive pathogen Salmonella typhimutium. Infect Immun, 1992, 60:1786-1792.
  • 10Phalipon A, Kaufmann M, Michetti P, et al. Monoclonal Immunoglobulin A antibody directed against Serotype-specific epitope of Shigella flexneri lipopolysaccharide protects against murine experimental shigellosis. J Exp Med, 1995, 182:769-778.

同被引文献72

引证文献9

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部